Galapagos NV (GLPGF)
OTCMKTS · Delayed Price · Currency is USD
33.45
0.00 (0.00%)
Aug 26, 2025, 8:00 PM EDT
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $2.16 billion as of August 28, 2025. Its market cap has increased by 32.33% in one year.
Market Cap
2.16B
Enterprise Value
-1.43B
Revenue
323.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
$33.45
Market Cap Chart
Since March 31, 2014, Galapagos NV's market cap has increased from 656.84M to 2.16B, an increase of 229.23%. That is a compound annual growth rate of 11.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 2.16B | 19.22% |
| Dec 31, 2024 | 1.81B | -32.85% |
| Dec 29, 2023 | 2.69B | -7.39% |
| Dec 30, 2022 | 2.91B | -20.71% |
| Dec 31, 2021 | 3.67B | -43.02% |
| Dec 31, 2020 | 6.44B | -52.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 636.43M |
| Elite Pharmaceuticals | 594.22M |
| CytoDyn | 388.66M |
| Northwest Biotherapeutics | 357.21M |
| American Oncology Network | 357.05M |